The NEJM publishes phase 3 PEGASUS study results comparing pegcetacoplan to eculizumab for PNH

STOCKHOLM, Sweden and WALTHAM, Massachusetts, March 18, 2021 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that The New England Journal of Medicine (NEJM) published results from the phase 3 PEGASUS...

from PR Newswire: https://ift.tt/3c1ngdr